- Home
- PRTS vs AVTX Comparison
PRTS vs AVTX Comparison
Compare PRTS & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTS
- AVTX
- Stock Information
- Founded
- PRTS 1995
- AVTX 2011
- Country
- PRTS United States
- AVTX United States
- Employees
- PRTS N/A
- AVTX N/A
- Industry
- PRTS Auto & Home Supply Stores
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- PRTS Consumer Discretionary
- AVTX Health Care
- Exchange
- PRTS Nasdaq
- AVTX Nasdaq
- Market Cap
- PRTS 51.3M
- AVTX 57.4M
- IPO Year
- PRTS 2007
- AVTX 2015
- Fundamental
- Price
- PRTS $0.78
- AVTX $4.76
- Analyst Decision
- PRTS Buy
- AVTX Strong Buy
- Analyst Count
- PRTS 2
- AVTX 7
- Target Price
- PRTS $1.40
- AVTX $31.00
- AVG Volume (30 Days)
- PRTS 426.6K
- AVTX 100.3K
- Earning Date
- PRTS 07-29-2025
- AVTX 08-11-2025
- Dividend Yield
- PRTS N/A
- AVTX N/A
- EPS Growth
- PRTS N/A
- AVTX N/A
- EPS
- PRTS N/A
- AVTX N/A
- Revenue
- PRTS $569,935,000.00
- AVTX $441,000.00
- Revenue This Year
- PRTS $1.73
- AVTX N/A
- Revenue Next Year
- PRTS $5.48
- AVTX N/A
- P/E Ratio
- PRTS N/A
- AVTX N/A
- Revenue Growth
- PRTS N/A
- AVTX N/A
- 52 Week Low
- PRTS $0.68
- AVTX $3.39
- 52 Week High
- PRTS $1.45
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- PRTS 42.34
- AVTX 54.23
- Support Level
- PRTS $0.70
- AVTX $4.50
- Resistance Level
- PRTS $0.95
- AVTX $5.02
- Average True Range (ATR)
- PRTS 0.05
- AVTX 0.36
- MACD
- PRTS -0.01
- AVTX 0.05
- Stochastic Oscillator
- PRTS 31.64
- AVTX 72.92
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).